Filing Details
- Accession Number:
- 0001562180-21-002047
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2021-03-05 20:54:43
- Reporting Period:
- 2020-12-31
- Accepted Time:
- 2021-03-05 20:54:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1689813 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1704256 | Charles Conway | C/O Biohaven Pharmaceuticals, Inc. 215 Church Street New Haven CT 06510 | Chief Scientific Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Disposition | 2020-06-17 | 4,000 | $72.15 | 4,009 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices from $72.05 - $72.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- This balance includes 731 shares that were acquired through the company Employee Share Purchase Plan on November 30, 2020.
Billionaire Hedge Funds
